These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 23458386)

  • 1. Folate-appended β-cyclodextrin as a promising tumor targeting carrier for antitumor drugs in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Bioconjug Chem; 2013 Apr; 24(4):724-33. PubMed ID: 23458386
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and evaluation of folate-appended α-, β-, and γ-cyclodextrins having a caproic acid as a tumor selective antitumor drug carrier in vitro and in vivo.
    Okamatsu A; Motoyama K; Onodera R; Higashi T; Koshigoe T; Shimada Y; Hattori K; Takeuchi T; Arima H
    Biomacromolecules; 2013 Dec; 14(12):4420-8. PubMed ID: 24175976
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Folate-appended cyclodextrin carrier targets ovarian cancer cells expressing the proton-coupled folate transporter.
    Saito S; Koya Y; Kajiyama H; Yamashita M; Kikkawa F; Nawa A
    Cancer Sci; 2020 May; 111(5):1794-1804. PubMed ID: 32154964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of mitophagy-mediated antitumor activity with folate-appended methyl-β-cyclodextrin.
    Kameyama K; Motoyama K; Tanaka N; Yamashita Y; Higashi T; Arima H
    Int J Nanomedicine; 2017; 12():3433-3446. PubMed ID: 28496320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-PEG-appended dendrimer conjugate with α-cyclodextrin as a novel cancer cell-selective siRNA delivery carrier.
    Arima H; Yoshimatsu A; Ikeda H; Ohyama A; Motoyama K; Higashi T; Tsuchiya A; Niidome T; Katayama Y; Hattori K; Takeuchi T
    Mol Pharm; 2012 Sep; 9(9):2591-604. PubMed ID: 22873579
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Active Drug Targeting of a Folate-Based Cyclodextrin-Doxorubicin Conjugate and the Cytotoxic Effect on Drug-Resistant Mammary Tumor Cells In Vitro.
    Mizusako H; Tagami T; Hattori K; Ozeki T
    J Pharm Sci; 2015 Sep; 104(9):2934-40. PubMed ID: 25940848
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential use of folate-polyethylene glycol (PEG)-appended dendrimer (G3) conjugate with α-cyclodextrin as DNA carriers to tumor cells.
    Arima H; Arizono M; Higashi T; Yoshimatsu A; Ikeda H; Motoyama K; Hattori K; Takeuchi T; Hirayama F; Uekama K
    Cancer Gene Ther; 2012 May; 19(5):358-66. PubMed ID: 22402627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dual targeting system by supramolecular complex of folate-conjugated methyl-β-cyclodextrin with adamantane-grafted hyaluronic acid for the treatment of colorectal cancer.
    Elamin KM; Motoyama K; Higashi T; Yamashita Y; Tokuda A; Arima H
    Int J Biol Macromol; 2018 Jul; 113():386-394. PubMed ID: 29486262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carboxymethyl-β-cyclodextrin conjugated nanoparticles facilitate therapy for folate receptor-positive tumor with the mediation of folic acid.
    Su C; Li H; Shi Y; Wang G; Liu L; Zhao L; Su R
    Int J Pharm; 2014 Oct; 474(1-2):202-11. PubMed ID: 25149123
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential use of the complex of doxorubicin with folate-conjugated methyl-β-cyclodextrin for tumor-selective cancer chemotherapy.
    Motoyama K; Onodera R; Okamatsu A; Higashi T; Kariya R; Okada S; Arima H
    J Drug Target; 2014 Oct; 22(3):211-219. PubMed ID: 24219311
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Development of Cyclodextrin-based Cancer Treatment].
    Motoyama K
    Yakugaku Zasshi; 2015; 135(11):1291-8. PubMed ID: 26521878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In Vitro and In Vivo Co-delivery of siRNA and Doxorubicin by Folate-PEG-Appended Dendrimer/Glucuronylglucosyl-β-Cyclodextrin Conjugate.
    Mohammed AFA; Higashi T; Motoyama K; Ohyama A; Onodera R; Khaled KA; Sarhan HA; Hussein AK; Arima H
    AAPS J; 2019 Apr; 21(4):54. PubMed ID: 30993472
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potential use of folate-appended methyl-β-cyclodextrin as an anticancer agent.
    Onodera R; Motoyama K; Okamatsu A; Higashi T; Arima H
    Sci Rep; 2013; 3():1104. PubMed ID: 23346361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tumor drug delivery system based on cyclodextrin-containing pH-responsive star polymer: in vitro and in vivo evaluation.
    Xiong Q; Zhang M; Zhang Z; Shen W; Liu L; Zhang Q
    Int J Pharm; 2014 Oct; 474(1-2):232-40. PubMed ID: 25149124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folate-functionalized unimolecular micelles based on a degradable amphiphilic dendrimer-like star polymer for cancer cell-targeted drug delivery.
    Cao W; Zhou J; Mann A; Wang Y; Zhu L
    Biomacromolecules; 2011 Jul; 12(7):2697-707. PubMed ID: 21619062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of antitumor effects of folate-conjugated methyl-β-cyclodextrin in melanoma.
    Motoyama K; Onodera R; Tanaka N; Kameyama K; Higashi T; Kariya R; Okada S; Arima H
    Biol Pharm Bull; 2015; 38(3):374-9. PubMed ID: 25757918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific antitumor targetable beta-cyclodextrin-poly(ethylene glycol)-folic acid drug delivery bioconjugate.
    Salmaso S; Semenzato A; Caliceti P; Hoebeke J; Sonvico F; Dubernet C; Couvreur P
    Bioconjug Chem; 2004; 15(5):997-1004. PubMed ID: 15366952
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folate-mediated poly(3-hydroxybutyrate-co-3-hydroxyoctanoate) nanoparticles for targeting drug delivery.
    Zhang C; Zhao L; Dong Y; Zhang X; Lin J; Chen Z
    Eur J Pharm Biopharm; 2010 Sep; 76(1):10-6. PubMed ID: 20472060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.